Guggenheim Initiates Coverage of Entera Bio with Buy
Published . Updated .
Fintel reports that on September 25, 2026, Guggenheim initiated coverage of Entera Bio (NASDAQCM:ENTX) (DB:5DT) with a Buy recommendation.This initiation follows other recent analyst actions. On September 22, 2026, Cantor Fitzgerald initiated coverage of the company with an Overw
Directly affected
- ENTX Entera Bio
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Fintel reports that on September 25, 2026, Guggenheim initiated coverage of Entera Bio (NASDAQCM:ENTX) (DB:5DT) with a Buy recommendation.This initiation follows other recent analyst actions. On September 22, 2026, Cantor Fitzgerald initia…
Source: Nasdaq Markets
Entera Bio (ENTX) since this story, compared with the market
Since the first closing price after “Guggenheim Initiates Coverage of Entera Bio with Buy,” Entera Bio (ENTX) is +8.96%. The S&P 500 fund (SPY) is +0.15% over the same days, a +8.81% difference versus the market.
Who gains and who loses around Entera Bio (ENTX)
Companies mentioned with this story
- ENTX Entera Bio
In “Guggenheim Initiates Coverage of Entera Bio with Buy,” Entera Bio (ENTX) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names ENTERA BIO LTD in the headline; GA resolved that company to ENTX
How “Guggenheim Initiates Coverage of Entera Bio with Buy” reaches Entera Bio (ENTX)
Entera Bio (ENTX) is the company in “Guggenheim Initiates Coverage of Entera Bio with Buy,” the 25 Sep 2026 this story story.
What ties Entera Bio (ENTX) to the headline is this: The reported development directly names ENTERA BIO LTD in the headline; GA resolved that company to ENTX
The price range for Entera Bio (ENTX), and the dates in the story
ENTX traded between 2.44 and 3.03 across 20 sessions. The latest close on file is 2.92.
How strong the case is around Entera Bio (ENTX)
14 out of 100
“Guggenheim Initiates Coverage of Entera Bio with Buy” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.